Clinical Trial Update: Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the addition of serelaxin to standard therapy in acute heart failure has completed and posted results for efficacy, safety and tolera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Serelaxin (serelaxin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2018-03-30